LEVELS OF PLASMA SOLUBLE CD14 IN HIV-INFECTED OPIATE USERS

Chronic immune activation is one of the main causes of HIV disease progression. Bacterial components passed to the bloodstream from the gut as a result of microbial translocation, are known to induce immune activation. Component of Gram-negative bacteria’s cell walls, the lipopolysaccharide (LPS), is considered to be the major marker of microbial translocation. Through the activation of myeloid cells (predominantly monocytes) LPS causes the secretion of soluble CD14, thus making it a marker of LPS bioactivity. Besides sCD14 was shown to correlate with immune status in HIVinfected patients and to be an independent predictor of disease progression.

Hypothesis: opiates increase microbial translocation from the gut in HIV-infected patients that is manifested by a higher concentration of sCD14 in plasma.

Aim: to estimate the influence of opiate use on the level of sCD14 in plasma of HIV-infected patients.

Materials and methods. Longitudinal study of 351 HIV positive individuals. Concentration of sCD14, was evaluated at 3 time points: baseline, after 12 and 24 months. Following groups were studied: 1) current opiate users – opiate use within past 30 days; 2) opiate users, who denied consumption of opiates within past 30 days; 3) people claiming to never have used opiates.

Results. In dynamic assessment sCD14 mean was significantly higher in current opiate users (2222,46±39,02 ng/ml) against patients who denied opiates within past 30 days (1930±597 ng/ml) and those, claiming to never have used opiates (1915±577 ng/ml) (p<0,001).

Conclusion. Opiate use in the course of HIV disease leads to increase in LPS induced monocyte activation which therefore signifies more intensive microbial translocation.

1. Brenchley JM et al. Microbial translocation is a cause of systemic immune activation in chronic HIV. Nat. Med. 2006;12:1365-1371.

2. Marchetti G et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count . AIDS. 2011; 25(11):1385-94.

3. Klatt NR et al. Microbial translocation, immune activation and HIV disease . Trends Microbiol. 2013; 21(1): 6-13.

4. Nowroozalizadeh S. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis. 2010; 201(8):1150–1154.

5. Brenchley JM et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 2004; 200(6):749-759.

6. Epple HJ et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIVinfected patients .Gut. 2009; 58:220–227.

7. Dillon SM et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 2014; 7:983–994.

8. Meng J, Yu H, Ma J, Wang J, Banerjee S, Charboneau R et al. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-Dependent manner. PLoS ONE. 2013; 8:e54040.

9. Babrowski T, Holbrook C, Moss J, Gottlieb L, Valuckaite V, Zaborin A et al. Pseudomonas aeruginosa virulence expression is directly activated by morphine and is capable of causing lethal gut-derived sepsis in mice during chronic morphine administration. Ann. Surg. 2012; 255: 386–393.

10. Hilburger ME, Adler MW, Truant AL, Meissler JJ, Satishchandran V, Rogers T J, et al. Morphine induces sepsis in mice. J. Infect. Dis. 1997; 176: 183–188.

11. Sindberg GM, Sharma U, Banerjee S, Anand V, Dutta R, Gu CJ, et al. An infectious murine model for studying the systemic effects of opioids on early HIV pathogenesis in the gut. J. Neuroimmune Pharmacol. 2014; 10: 74–87.

12. Donahoe RM, Vlahov D. Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol. 1998;83(1-2):77-87.

13. Richard J, Noel Jr, et al. Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model. J Neurovirol. 2008; 14(4): 279–285.

14. Krastinova E, Lecuroux C, Leroy C, Seng R, Cabie A et al. High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression. The Journal of Infectious Diseases. 2015; 212(6): 909–913.

15. Sandler NG, Wand H, Roque A, et al. Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection. The Journal of Infectious Diseases. 2011;203(6):780-790.

16. Karris MY, Kao Y, Patel D, et al. Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection. AIDS (London, England). 2014;28(6):841-849.

17. Khasanova GR, Bikkinina OI, Anokhin VA. Mikrobnaya translokatsiya i sistemnyy vospalitel’nyy otvet pri VIChinfektsii. Saratovskiy nauchno-meditsinskiy zhurnal. 2013; 9(3): 508–512 (in Russian).

18. Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE. 2008; 3:e2516.